Ketoconazol Korhispana

Ketoconazole, the active ingredient in Ketoconazol Korhispana, is a azole antifungal presented as a topical formulation for cutaneous use. It treats fungal skin infections such as tinea and seborrheic dermatitis in patients requiring topical therapy.

GNH USA supplies Ketoconazol Korhispana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoconazole is an azole antifungal used to treat a range of superficial fungal infections. - Tinea corporis: reduces erythema and scaling caused by dermatophyte infection. - Tinea cruris: alleviates itching and rash in the groin area. - Tinea pedis: clears foot skin infection and prevents spread. - Pityriasis versicolor: restores normal skin pigmentation by eliminating Malassezia species. - Seborrheic dermatitis: controls flaking and redness on scalp and face.

Ketoconazole may cause local and systemic reactions when applied to the skin.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Redness or mild erythema. - Dryness or peeling of the treated skin. - Contact dermatitis in sensitive individuals.

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, anaphylaxis). - Extensive skin irritation or ulceration. - Hepatotoxicity reflected by abnormal liver enzymes. - Hormonal disturbances such as gynecomastia. - Photosensitivity leading to exaggerated sunburn.

When using Ketoconazol Korhispana, consider the following safety measures. - Avoid application on broken or inflamed skin: may increase systemic absorption. - Limit use to the prescribed area: excessive coverage can raise risk of irritation. - Do not use under occlusive dressings unless directed: can enhance drug penetration. - Monitor for signs of allergic reaction: discontinue if severe rash develops. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Ketoconazole can interact with other topical agents and systemic medications.

Major Interactions (Avoid): - Concurrent use with other potent topical corticosteroids: may increase skin atrophy risk. - Systemic azole antifungals: can lead to cumulative hepatotoxicity.

Moderate Interactions (Monitor Closely): - Topical retinoids: may cause increased irritation. - Alcohol‑containing skin products: could enhance local irritation. - Phototoxic agents: monitor for heightened photosensitivity.